Frederick, MD · Founded 2017 · Privately Held (backing)
Developer of small molecule therapeutics designed to target heparin-induced thrombocytopenia and thrombosis. Veralox Therapeutics is based in Frederick, MD and was founded in 2017. It was valued at $66 million at its later-stage round in Jun 2023, the last priced event on record. It has raised $41.2 million across 3 recorded rounds; the latest was a $24 million early-stage round in Jun 2023.
PMV mark · valuation
$66.0M
Oct 2026
Priced at
its later-stage round
Jun 2023
Total raised
$41.2M
Last round
Early Stage VC
Jun 2023
Cap table — not yet on record
Veralox Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Veralox Therapeutics with a free account
·The complete investor list: 15 names
·Watch Veralox Therapeutics: the Monday email on marks, rounds and moves
Where does Veralox Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Veralox Therapeutics's 3 recorded funding rounds.
